$QUCY Balance Sheet | Understand Stock

$QUCY

$0.96 +$0.05 (6.07%) Close

$QUCY Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Aug 12, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q4 FY2021 As of Dec 31, 2021
Cash
Trade receivables, net
Trade receivables - related party
Inventories
Prepaid expenses and other current assets
Total current assets
Property and equipment, net
Intangible asset
Right-of-use assets, net
Other assets
Total assets
Accrued payroll
Accounts payable and accrued liabilities
Accounts payable and accrued expense - related party
Related Parties
Total accounts payable and accrued expense - related party
Deferred revenue
Convertible debt
Loans payable
Loans payable – related party
Silent partnership – related party
Convertible debt - related party
Silent partnership
Silent partnership - related party
Intellectual property acquisition liability - related party
Lease liabilities
Total current liabilities
Silent partnerships – related party
Silent partnerships
Silent partnerships - related party
Total liabilities
Share capital
Share premium
Reserve
Total shareholders’ equity
Current Assets
Cash
Accounts receivable
Accounts receivable - related party
Inventories
Prepaid expenses and other current assets
Assets of discontinued operations, held for sale
Total current assets
Property and equipment, net
Intangible assets
Right-of-use assets
Total assets
Current Liabilities
Accounts payable and accrued liabilities
Accounts payable and accrued liabilities - related party
Loan payable
Convertible debt
Notes payable - Silent partnership
Intellectual property acquisition liability
Operating lease liabilities - current portion
Liabilities of discontinued operations, held for sale
Total current liabilities
Operating lease liabilities
Intellectual property acquisition liability - related party
Total liabilities
Shareholders' equity
Preferred share
Ordinary shares, a par value of € 0.01, 45,000,000 shares authorized, 12,515,336 and 9,780,142 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively
Additional paid-in capital
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Total shareholders' equity
Total liabilities and shareholders’ equity

Comments